Solifenacin (INN trade name Vesicare) is a medicine of the antimuscarinic class and was developed for treating contraction of overactive bladder with urge incontinence. It is manufactured and marketed by AstellasTeva Pharmaceutical Industries and GlaxoSmithKline
This page contains content from the copyrighted Wikipedia article "Solifenacin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.